Yao Cheng

Efficacy and safety of dolutegravir with emtricitabine and tenofovir alafenamide fumarate or tenofovir disoproxil fumarate, and efavirenz, emtricitabine, and tenofovir disoproxil fumarate HIV antiretroviral therapy regimens started in pregnancy (IMPAACT 2010/VESTED): a multicentre, open-label, randomised, controlled, phase 3 trial

Shahin Lockman, Sean S. Brummel, Lauren Ziemba et al. · The Lancet · 2021 · 160 citations · Full text

Medicine, Obstetrics, Pharmacotherapy +16

An Albumin-Conjugated Peptide Exhibits Potent Anti-HIV Activity and Long<i>In Vivo</i>Half-Life

Dong Xie, Yao Cheng, Li Wang et al. · Antimicrobial Agents and Chemotherapy · 2009 · 84 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +17

Efficacy and safety of the long-acting fusion inhibitor albuvirtide in antiretroviral-experienced adults with human immunodeficiency virus-1: interim analysis of the randomized, controlled, phase 3, non-inferiority TALENT study

Bin Su, Yao Cheng, Qingxia Zhao et al. · Chinese Medical Journal · 2020 · 49 citations · Full text

Pharmacy, Clinical Pharmacokinetics, Pharmacotherapy +17

Combination of long-acting HIV fusion inhibitor albuvirtide and LPV/r showed potent efficacy in HIV-1 patients

Hongwei Zhang, Ronghua Jin, Yao Cheng et al. · AIDS Research and Therapy · 2016 · 39 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Evaluation of pharmacokinetic interactions between long-acting HIV-1 fusion inhibitor albuvirtide and lopinavir/ritonavir, in HIV-infected subjects, combined with clinical study and simulation results

Wanqiu Yang, Qingqing Xiao, Dan Wang et al. · Xenobiotica · 2016 · 19 citations

Pharmacy, Pharmacokinetics, Pharmacology +17